Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protrans in Children and Adolescents with Type 1 Diabetes
NCT05061030Phase 2Active, not recruiting
- Sponsor
- Akademiska sjukhuset
- Start
- Jan 2022
- Primary completion
- Sep 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of ProTrans in type 1 diabetes mellitus (T1D), sponsored by Akademiska sjukhuset. Started Jan 2022; status: active, not recruiting.
02
Drugs
ProTrans
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05061030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05061030.